Screening for and Treating Testosterone Deficiency in Male Diabetic Patients

Tuesday, 14th May 2019

19:00 (60 mins)


In this webinar, consideration will be given to the evidence for the targeted screening of hypogonadism amongst the male diabetic population and the role of testosterone replacement therapy as part of a holistic strategy in managing their hypogonadism.

  • Prevalence of TD and Diabetes
  • Physiology
  • Evidence base for treating TD in male diabetic patients
  • Manage of TD in Diabetic male patients


Dr Kam Mann


Men’s Health Physician with specialist interests in Sexual medicine and Andrology.

London, Winchester and Southampton, United Kingdom

Kam is an experienced Physician with a specialist interest in Men’s Health, Sexual medicine and Andrology. He completed the Multidisciplinary Joint Committee of Sexual Medicine (MJCSM) course and is a Fellow of the European Committee of Sexual Medicine (FECSM). He continues to work in the NHS Andrology unit at University Hospital Southampton and privately with The Mann Clinic with clinics in London, Winchester and Southampton.

He performs assessments on patients with testosterone deficiency, erectile dysfunction, penile rehabilitation, premature ejaculation, delayed ejaculation, cancer and sexuality problems and Men’s health and wellness.

He is treasurer of the British Society for Sexual Medicine (BSSM) and a Member of the European and International Societies of Sexual Medicine (ESSM, ISSM). He is a co-author of the Men’s Health Guidelines for General Practice.

Dr. Mann has been invited as a speaker and chaired scientific meetings in the field of Men’s health, Sexual medicine and Andrology.

Professor Hugh Jones

Consultant Physician General Medicine

Diabetes and Endocrinology - Barnsley Hospital, Consultant Endocrinologist – Royal Hallamshire Hospital

Sheffield, UK

Professor Hugh Jones is a Consultant Physician in general internal medicine, diabetes and endocrinology at Barnsley Hospital. He is also an Honorary Professor of Andrology in the Department of Human Metabolism the University of Sheffield Medical School, Sheffield, UK and Hon. Consultant Endocrinologist at the Royal Hallamshire Hospital, Sheffield.

Prof. Jones is a clinical and laboratory researcher, looking into the role of testosterone in the pathogenesis and treatment of various conditions and pathologies. His major scientific discoveries are many and varied including for example determining the mechanisms of action of testosterone as an arterial vasodilator (L-channel calcium blocker).

He was elected to the European Academy of Andrology and is a co-chair of the testosterone and metabolic disorders group as part of the International Consultation on Men’ Health and Infertility to be submitted to the WHO). He is a Member of the European Association of Urology Guideline committee for Male Hypogonadism and Chair of Academic sub-committee of ABCD.

Register now

Restore the man is organised and funded by Bayer and may contain some promotional content.

Licensed for:
In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

This website is intended for Healthcare Professionals resident in the UK.